These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20826961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS.
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Anesth Analg; 2010 Apr 01; 110(4):1239. PubMed ID: 20357160
    [Abstract] [Full Text] [Related]

  • 6. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM.
    Anesthesiology; 2007 May 01; 106(5):935-43. PubMed ID: 17457124
    [Abstract] [Full Text] [Related]

  • 7. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug 01; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 8. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, Wulf H.
    Anesthesiology; 2009 Jul 01; 111(1):30-5. PubMed ID: 19512873
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of sugammadex.
    Caldwell JE, Miller RD.
    Anaesthesia; 2009 Mar 01; 64 Suppl 1():66-72. PubMed ID: 19222433
    [Abstract] [Full Text] [Related]

  • 10. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
    Rex C, Bergner UA, Pühringer FK.
    Curr Opin Anaesthesiol; 2010 Aug 01; 23(4):461-5. PubMed ID: 20489603
    [Abstract] [Full Text] [Related]

  • 11. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK.
    Anesthesiology; 2009 Feb 01; 110(2):284-94. PubMed ID: 19194156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preclinical pharmacology of sugammadex.
    Bom A, Hope F, Rutherford S, Thomson K.
    J Crit Care; 2009 Mar 01; 24(1):29-35. PubMed ID: 19272536
    [Abstract] [Full Text] [Related]

  • 16. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G, Pompei L.
    Minerva Anestesiol; 2009 May 01; 75(5):349-51. PubMed ID: 19412157
    [Abstract] [Full Text] [Related]

  • 17. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL.
    J Clin Anesth; 2009 Sep 01; 21(6):444-53. PubMed ID: 19833281
    [Abstract] [Full Text] [Related]

  • 18. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME.
    Anesth Analg; 2009 Mar 01; 108(3):846-51. PubMed ID: 19224792
    [Abstract] [Full Text] [Related]

  • 19. Neuromuscular transmission: new concepts and agents.
    de Boer HD.
    J Crit Care; 2009 Mar 01; 24(1):36-42. PubMed ID: 19272537
    [Abstract] [Full Text] [Related]

  • 20. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar 01; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.